Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Holtick

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Retinal Cases & Brief Reports|January 25, 2021
LONG-TERM FOLLOW-UP OF ASYMMETRIC BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION IN A PATIENT WITH METASTASIZED UROTHELIAL CARCINOMAAnna M Lentzsch, Robert Siggel, Christel Schnorr, et al.
The Cochrane Database of Systematic Reviews|November 7, 2024
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsSinje Kiene, Melanie Albrecht, Sebastian Theurich, et al.
Annals of Hematology|May 6, 2021
What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?Steffen T Simon, Anne Pralong, Michael Hallek, et al.
Expert Opinion on Investigational Drugs|January 25, 2011
Toll-like receptor 9 agonists as cancer therapeuticsUdo Holtick, Max E Scheulen, Michael S von Bergwelt-Baildon, et al.
Cancers|June 2, 2021
Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature ReviewFreya Wenzel, Anne Pralong, Udo Holtick, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 3, 2022
Clinical exercise therapy program with multiple myeloma patients: Impacts on feasibility, adherence and efficacyMichael Mendes Wefelnberg, Timo Niels, Udo Holtick, et al.
Oncology Research and Treatment|July 23, 2023
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer CenterJennifer Bonn, Christoph T Baltin, Viola Osterkamp, et al.
Transplantation|March 14, 2008
Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cellsUdo Holtick, Scott R Marshall, Xiao-Nong Wang, et al.
European Journal of Haematology|February 5, 2024
Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantationNadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin, et al.
Expert Review of Vaccines|March 26, 2011
Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphomaNela Klein-González, Udo Holtick, Kirsten Fairfax, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Retinal Cases & Brief Reports|January 25, 2021
LONG-TERM FOLLOW-UP OF ASYMMETRIC BILATERAL DIFFUSE UVEAL MELANOCYTIC PROLIFERATION IN A PATIENT WITH METASTASIZED UROTHELIAL CARCINOMAAnna M Lentzsch, Robert Siggel, Christel Schnorr, et al.
The Cochrane Database of Systematic Reviews|November 7, 2024
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adultsSinje Kiene, Melanie Albrecht, Sebastian Theurich, et al.
Annals of Hematology|May 6, 2021
What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?Steffen T Simon, Anne Pralong, Michael Hallek, et al.
Expert Opinion on Investigational Drugs|January 25, 2011
Toll-like receptor 9 agonists as cancer therapeuticsUdo Holtick, Max E Scheulen, Michael S von Bergwelt-Baildon, et al.
Cancers|June 2, 2021
Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature ReviewFreya Wenzel, Anne Pralong, Udo Holtick, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 3, 2022
Clinical exercise therapy program with multiple myeloma patients: Impacts on feasibility, adherence and efficacyMichael Mendes Wefelnberg, Timo Niels, Udo Holtick, et al.
Oncology Research and Treatment|July 23, 2023
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer CenterJennifer Bonn, Christoph T Baltin, Viola Osterkamp, et al.
Transplantation|March 14, 2008
Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cellsUdo Holtick, Scott R Marshall, Xiao-Nong Wang, et al.
European Journal of Haematology|February 5, 2024
Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantationNadine Kutsch, Philipp Gödel, Conrad-Amadeus Voltin, et al.
Expert Review of Vaccines|March 26, 2011
Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphomaNela Klein-González, Udo Holtick, Kirsten Fairfax, et al.
Pageof 10